Stocky
GILD
Gilead Sciences, Inc.
NASDAQ · Healthcare · US
131.76
▼ -2.58%

What's happening at Gilead Sciences, Inc.

Gilead Sciences, Inc.'s latest moves, explained simply — so you know why the numbers change.

Straight from SEC filings · updated 6 Aug 2026
Big update 4 Aug 2026

Reports second quarter 2026 financial results

Investors learn if the company made more or less money than expected.

SEC 8-K · filed 2026-08-04 View filing ↗
Money 20 May 2026

Issues three billion dollars in senior debt notes

The company borrowed money by selling bonds, which affects future obligations.

SEC 8-K · filed 2026-05-20 View filing ↗
Money 18 May 2026

Updates bond offering prospectus for debt sale

Shows details about how the company is raising borrowed money.

SEC 424B5 · filed 2026-05-18 View filing ↗
Money 14 May 2026

Updates bond offering prospectus for debt sale

Shows details about how the company is raising borrowed money.

SEC 424B5 · filed 2026-05-14 View filing ↗
Earnings 7 May 2026

Files first quarter 2026 financial statements

Official records show the company's financial position three months into the year.

SEC 10-Q · filed 2026-05-07 View filing ↗
Earnings 7 May 2026

Reports first quarter 2026 financial results

Investors learn if the company made more or less money than expected.

SEC 8-K · filed 2026-05-07 View filing ↗
Governance 4 May 2026

Stockholders elect nine directors and approve auditor

Owners voted on who leads the company and who checks its finances.

SEC 8-K · filed 2026-05-04 View filing ↗

Common questions

How does Stocky track Gilead Sciences, Inc.'s company events?

Stocky reads Gilead Sciences, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.

What was Gilead Sciences, Inc.'s most recent SEC filing?

Gilead Sciences, Inc.'s most recent tracked filing was a 8-K on 4 Aug 2026: Reports second quarter 2026 financial results.

Is this financial advice?

No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.

See Gilead Sciences, Inc.'s full breakdown on Stocky →

Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.